Association between serum lipase levels and chronic kidney disease stages
Serum lipase emerges as a novel biomarker for CKD stages, exhibiting stage-dependent increases and independent prognostic significance. Regular testing could improve risk assessment and complement current markers like eGFR and proteinuria, enhancing CKD management.
Authors
- Zuojie Li
- Gui Zhang (ORCID: https://orcid.org/0000-0002-1123-7877)
- Chunyan Xu
Institutions
- Wenzhou Medical University (CN)
- People’s Hospital of Linqing (CN)
- Hangzhou Hospital of Traditional Chinese Medicine (CN)
- Wenzhou City People's Hospital (CN)
- Zhejiang Taizhou Hospital (CN)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-08-18
- DOI
- https://doi.org/10.1371/journal.pone.0330329
- Primary Topic
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Type
- article
- Field-Weighted Citation Impact
- 0.00